ema semaglutide European Medicines Agency to investigate link between Ozempic and rare eye disorder A potentially blinding condition is

It is advised to take this medicine at a fixed time to avoid missing a dose

In its advice published in December, PBAC noted there was a "significant risk" that people who did not meet the two criteria and particularly those who met one threshold but not the other would seek access to the subsidised drugs and therefore that a "risk sharing arrangement" with the company would be needed to manage the cost to the government

Avoiding prescriptions on principle leads some to a wearable supplement

doi: 10.1111/obr.13296

BPC-157 staat op de dopinglijst van het wereldantidopingbureau WADA, in de categorie van niet-goedgekeurde stoffen die altijd verboden zijn

2006 Sep;113(9):1508.e1-25